• EHA: Epizyme's first-in-class multiple myeloma drug candidate inhibits tumors in mice

    1 month ago - By Fierce Biotech

    EHA: Epizyme's first-in-class multiple myeloma drug candidate inhibits tumors in mice aliu
    Mon, 06/14/2021 - 05:39
    Read more ...